Crinetics Pharmaceuticals (NASDAQ:CRNX) has outperformed the market over the past 5 years by 21.74% on an annualized basis producing an average annual return of 33.07%. Currently, Crinetics Pharmaceuticals has a market capitalization of $8.84 billion.
Buying $1000 In CRNX: If an investor had bought $1000 of CRNX stock 5 years ago, it would be worth $4,029.44 today based on a price of $83.49 for CRNX at the time of writing.
Crinetics Pharmaceuticals’s Performance Over Last 5 Years
Finally -- what’s the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Login to comment